[Study of cellular inflammatory response with bronchoalveolar lavage in allergic asthma, aspirin asthma and in extrinsic infiltrating alveolitis]. 2002

Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer

The asthmatic inflammatory responses present different type of cells involved in this process, such as: Lymphocytes and Eosinophils. In experienced hands the bronchoalveolar lavage (BAL) is a well-tolerated and valuable tool for investigation of basic mechanisms in asthma and other immunological respiratory diseases. The purpose of this work was to study the different cells involved in asthmatic inflammatory responses in allergic and aspirin sensitivity patients and compared with Extrinsic Allergic Alveolitis patients (EAA) by BAL procedure. We studied 27 asthmatic patients. This group was divided by etiological conditions in: allergic asthmatic patients (a) (n: 19), (9 male and 10 female) demonstrated by reversible fall of FEV 1 (3) 20% and 2 or more positive skin test for common aeroallergens. The aspirin asthmatic patients (b) (n: 8) (5 male and 3 female) demonstrated by progressive challenge with aspirin and fall of FEV 1 (3) 20%. The third group with compatible symptoms and signs of EAA, demonstrated by lung biopsy, (n: 9) (8 male and 1 female) (c). We determined in all patients: Total IgE serum level by ELISA test. BAL was performed by standard procedure in all patients. The cells count were performed in BAL and were separated in Eosinophils, T lymphocytes defined by monoclonal anti CD 3 antibody, Lymphocytes CD 4 and CD 8 by monoclonal anti CD 4 and CD 8 antibodies respectively. The B lymphocytes defined by surface immunoglobulin isotypes IgG, IgM, IgA and IgE. The IgE level was in (a) 630 +/- 350 kU/L, in (b) it was 85 +/- 62 kU/L and in EAA (c) 55 +/- 23 kU/L, p < .0005. Eosinophil percentage in (a) was 25 +/- 13% of cells, in (b) was 28 +/- 15% of cells, NS, and 0 in (c), p < .0005. Lymphocytes T level was 43 +/- 15% of cells in (a), it was 32 +/- 15% of cells in (b) and it was 54 +/- 19% of cells in (c), NS. Lymphocytes CD 4 (+) level was 30 +/- 10% of cells in (a), it was 24 +/- 11% of cells in (b) and it was 8 +/- 6% of cells in (c), p < .005. Lymphocytes CD8 level was 8 +/- 6% of cells in (a), it was 7 +/- 4% of cells in (b) and it was 44 +/- 15% of cells in EAA (c), p < .005. Lymphocytes B level was 8 +/- 4% cells in (a), it was 2.9 +/- 2.5% cells in (b) and it was 3 +/- 2.7% of cells in (c), p < .025. The features described here suggest the importance of the Eosinophils and CD 4 +/- Lymphocytes in asthmatic response of allergic asthmatic patients as well as in aspirin sensitivity asthmatic patients. The LBA cellular profile of E.AA patients presented eosinophilia and CE8+ Lymphocite predominance when compared with both asthmatic cellular profile.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
January 1986, Respiration; international review of thoracic diseases,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
January 1987, European journal of respiratory diseases. Supplement,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
January 1992, Pneumonologia i alergologia polska,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
January 1988, Respiration; international review of thoracic diseases,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
July 1996, Polskie Archiwum Medycyny Wewnetrznej,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
September 2006, Postgraduate medical journal,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
September 1990, The European respiratory journal,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
November 1982, European journal of respiratory diseases,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
February 1986, Praxis und Klinik der Pneumologie,
Juan C Muiño, and Roberto Garnero, and Ricardo Caillet Bois, and María J Gregorio, and Mercedes Ferrero, and Marta Romero-Piffiguer
July 1990, Thorax,
Copied contents to your clipboard!